Literature DB >> 1599035

Hemangiomas of the breast with atypical histological features. Further analysis of histological subtypes confirming their benign character.

S A Hoda1, M L Cranor, P P Rosen.   

Abstract

Eighteen patients with vascular tumors of the breast that exhibited characteristics raising the question of but not qualifying for a diagnosis of low-grade angiosarcoma were reviewed. We had previously referred to these lesions as "atypical" hemangiomas because of concern regarding the diagnosis and the risk of the later development of angiosarcoma. Significant features, variably present, included small size (less than 2.0 cm), relative circumscription, broadly anastomosing vascular channels, and endothelial hyperplasia. Destructive invasion, solid areas, and hemorrhage or necrosis unrelated to a needle localization procedure were absent. Four distinct histological patterns were observed: cavernous, compact capillary, capillary budding, and a combined cavernous and compact capillary type. The age of the patients varied from 19 to 82 years (mean 60 years). Eleven tumors were detected mammographically. The size of the lesion ranged from 0.4 to 2.0 (mean 0.9) cm. The diagnostic biopsy was the only treatment in nine (50%) cases. Reexcision was performed in seven and mastectomy was done in two cases. Follow-up ranged from 1 to 140 (mean 44) months. There have been no local or systemic recurrences. Hemangiomas with diverse histological patterns have been detected clinically with the increasingly widespread use of mammography. Further follow-up indicates that the lesions originally referred to as "atypical" are benign and not associated with an appreciable risk of the development of angiosarcoma. Complete excision alone is recommended to treat these tumors, which may be diagnosed as hemangiomas and subclassified according to growth pattern.

Entities:  

Mesh:

Year:  1992        PMID: 1599035     DOI: 10.1097/00000478-199206000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Sinusoidal hemangioma of the breast: diagnostic evaluation management and literature review.

Authors:  Nikolaos S Salemis
Journal:  Gland Surg       Date:  2017-02

2.  Benign vascular lesions of the breast diagnosed by core needle biopsy do not require excision.

Authors:  Christopher Sebastiano; Lucas Gennaro; Edi Brogi; Elizabeth Morris; Zenica L Bowser; Cristina R Antonescu; Fresia Pareja; Sandra Brennan; Melissa P Murray
Journal:  Histopathology       Date:  2017-09-08       Impact factor: 5.087

3.  Breast Hemangioma Evaluation with Magnetic Resonance Imaging: A Rare Case Report.

Authors:  Özge Aslan; Ayşenur Oktay; Gürdeniz Serin; Levent Yeniay; Orkhan Aghamirzayev
Journal:  Eur J Breast Health       Date:  2022-04-01

4.  Primary benign vascular tumors and tumorlike lesions of the kidney: a clinicopathologic analysis of 15 cases.

Authors:  Vikas Mehta; Vijayalakshmi Ananthanarayanan; Tatjana Antic; Thomas Krausz; John Milner; Girish Venkataraman; Maria M Picken
Journal:  Virchows Arch       Date:  2012-10-23       Impact factor: 4.064

5.  A rare coexistence of concurrent breast hemangioma with fibroadenoma: a case report.

Authors:  Vibha Kawatra; Akhila Lakshmikantha; Kajal Kiran Dhingra; Parul Gupta; Nita Khurana
Journal:  Cases J       Date:  2009-05-15

6.  Anastomosing Hemangioma of the Breast: An Unusual Case at an Unusual Site.

Authors:  Michelle S Lin; Thu Ngo; Mary R Schwartz; Rajul R Mehta; Alberto G Ayala; Jae Y Ro
Journal:  J Breast Cancer       Date:  2020-02-17       Impact factor: 3.588

7.  Breast hemangioma with difficulty in preoperative diagnosis: a case report.

Authors:  Naotake Funamizu; Isao Tabei; Chikako Sekine; Azusa Fuke; Mitsuo Yabe; Hiroshi Takeyama; Tomoyoshi Okamoto
Journal:  World J Surg Oncol       Date:  2014-10-14       Impact factor: 2.754

8.  Hemangioma of the male breast: Presentation after thorn injury.

Authors:  Ali Imran Alwani; Mary R Schwartz; Barrett C Riddle; Richard Caplan; Lewis L Ware
Journal:  BJR Case Rep       Date:  2021-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.